Drug Shortage Report for POTASSIUM CHLORIDE INJECTION
Report ID | 58038 |
Drug Identification Number | 02241676 |
Brand name | POTASSIUM CHLORIDE INJECTION |
Common or Proper name | Potassium Chloride 10mmol in 100mL |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE |
Strength(s) | 7.46MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 100mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-08-13 |
Actual start date | 2018-08-13 |
Estimated end date | 2018-08-28 |
Actual end date | 2018-08-28 |
Shortage status | Resolved |
Updated date | 2018-08-29 |
Company comments | Alternative doses of high-concentration potassium chloride are available. Please consult your hospital pharmacy for acceptable clinical alternatives. E.g. 10mmol KCl in 50mL SWI (JB0821P) and 20mmol KCl in 100mL SWI (JB0827P). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-08-29 | French | Compare |
v4 | 2018-08-29 | English | Compare |
v3 | 2018-08-14 | English | Compare |
v2 | 2018-08-13 | French | Compare |
v1 | 2018-08-13 | English | Compare |
Showing 1 to 5 of 5